Brief: Tarsus Reports Third Quarter 2022 Financial Results

Tarsus Pharmaceuticals

09/11/2022 11:24

Nov 9 (Reuters) - Tarsus Pharmaceuticals Inc  TARS.O :
    * TARSUS REPORTS THIRD QUARTER 2022 FINANCIAL RESULTS AND
RECENT
BUSINESS ACHIEVEMENTS
    * NEW DRUG APPLICATION FOR TP-03 ACCEPTED; PDUFA TARGET
ACTION
DATE AUGUST 25, 2023
    * CASH RUNWAY ANTICIPATED INTO AT LEAST 2026 FOR THE PLANNED
COMMERCIAL LAUNCH OF TP-03 AND CONTINUED PIPELINE DEVELOPMENT
    * AS OF SEPTEMBER 30, 2022, CASH, CASH EQUIVALENTS AND
MARKETABLE
SECURITIES WERE $226.6 MILLION
    * QTRLY LOSS PER SHARE $0.84
    * Q3 EARNINGS PER SHARE VIEW $-0.97 -- REFINITIV IBES DATA

Further company coverage:  TARS.O 
 ((Reuters.Briefs@thomsonreuters.com;))